Cargando…
Prioritisation and design of clinical trials
Clinical trials require participation of numerous patients, enormous research resources and substantial public funding. Time-consuming trials lead to delayed implementation of beneficial interventions and to reduced benefit to patients. This manuscript discusses two methods for the allocation of res...
Autores principales: | Heath, Anna, Myriam Hunink, M. G., Krijkamp, Eline, Pechlivanoglou, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629779/ https://www.ncbi.nlm.nih.gov/pubmed/34091766 http://dx.doi.org/10.1007/s10654-021-00761-5 |
Ejemplares similares
-
Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials
por: Dijk, Stijntje W., et al.
Publicado: (2022) -
TADA—a machine learning tool for functional annotation-based prioritisation of pathogenic CNVs
por: Hertzberg, Jakob, et al.
Publicado: (2022) -
Development of a prioritisation tool for the updating of clinical guideline questions: the UpPriority Tool protocol
por: Martínez García, Laura, et al.
Publicado: (2017) -
Prioritizing Research in an Era of Personalized Medicine: The
Potential Value of Unexplained Heterogeneity
por: Heath, Anna, et al.
Publicado: (2022) -
Innovative approaches to investigator-initiated, multicentre paediatric clinical trials in Canada
por: Kelly, Lauren E, et al.
Publicado: (2019)